{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:44:57Z","timestamp":1793861097001,"version":"4.6.1"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-64181-9","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:36:44Z","timestamp":1760524604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Engineering a streamlined virus-like particle for programmable tissue-specific gene delivery"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7743-9092","authenticated-orcid":false,"given":"Jiabao","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6549-9362","authenticated-orcid":false,"given":"Qi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7864-404X","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"64181_CR1","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","volume":"14","author":"A Akinc","year":"2019","unstructured":"Akinc, A. et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat. Nanotechnol. 14, 1084\u20131087 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"64181_CR2","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"64181_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/liv.15090","volume":"42","author":"P Ventura","year":"2022","unstructured":"Ventura, P. et al. Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study. Liver Int. 42, 161\u2013172 (2022).","journal-title":"Liver Int."},{"key":"64181_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-020-6655-4","volume":"21","author":"C Breton","year":"2020","unstructured":"Breton, C., Clark, P. M., Wang, L., Greig, J. A. & Wilson, J. M. ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing. BMC Genom. 21, 239 (2020).","journal-title":"BMC Genom."},{"key":"64181_CR5","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1128\/JVI.72.5.4212-4223.1998","volume":"72","author":"K Jooss","year":"1998","unstructured":"Jooss, K., Yang, Y., Fisher, K. J. & Wilson, J. M. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J. Virol. 72, 4212\u20134223 (1998).","journal-title":"J. Virol."},{"key":"64181_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","volume":"185","author":"S Banskota","year":"2022","unstructured":"Banskota, S. et al. Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell 185, 250\u2013265.e216 (2022).","journal-title":"Cell"},{"key":"64181_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41551-020-00656-y","volume":"5","author":"S Ling","year":"2021","unstructured":"Ling, S. et al. Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice. Nat. Biomed. Eng. 5, 144\u2013156 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"64181_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07845-z","volume":"10","author":"PE Mangeot","year":"2019","unstructured":"Mangeot, P. E. et al. Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins. Nat. Commun. 10, 45 (2019).","journal-title":"Nat. Commun."},{"key":"64181_CR9","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.01911","volume":"3","author":"Y Cai","year":"2014","unstructured":"Cai, Y., Bak, R. O. & Mikkelsen, J. G. Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases. eLife 3, e01911 (2014).","journal-title":"eLife"},{"key":"64181_CR10","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1016\/j.ymthe.2023.08.021","volume":"31","author":"A Wei","year":"2023","unstructured":"Wei, A. et al. In vivo CRISPR gene editing in patients with herpetic stromal keratitis. Mol. Ther. 31, 3163\u20133175 (2023).","journal-title":"Mol. Ther."},{"key":"64181_CR11","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1126\/science.abg6155","volume":"373","author":"M Segel","year":"2021","unstructured":"Segel, M. et al. Mammalian retrovirus-like protein PEG10 packages its own mRNA and can be pseudotyped for mRNA delivery. Science 373, 882\u2013889 (2021).","journal-title":"Science"},{"key":"64181_CR12","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1021\/acs.biomac.2c01295","volume":"24","author":"DS Moreno-Gutierrez","year":"2023","unstructured":"Moreno-Gutierrez, D. S., del Toro-R\u00edos, X., Martinez-Sulvaran, N. J., Perez-Altamirano, M. B. & Hernandez-Garcia, A. Programming the cellular uptake of protein-based viromimetic nanoparticles for enhanced delivery. Biomacromolecules 24, 1563\u20131573 (2023).","journal-title":"Biomacromolecules"},{"key":"64181_CR13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/0042-6822(70)90083-8","volume":"41","author":"NH Acheson","year":"1970","unstructured":"Acheson, N. H. & Tamm, I. Purification and properties of Semliki Forest virus nucleocapsids. Virology 41, 306\u2013320 (1970).","journal-title":"Virology"},{"key":"64181_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1128\/mr.58.3.491-562.1994","volume":"58","author":"JH Strauss","year":"1994","unstructured":"Strauss, J. H. & Strauss, E. G. The alphaviruses: gene expression, replication, and evolution. Microbiological Rev. 58, 491\u2013562 (1994).","journal-title":"Microbiological Rev."},{"key":"64181_CR15","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1006\/jmbi.1994.1166","volume":"236","author":"C V\u00e9nien-Bryan","year":"1994","unstructured":"V\u00e9nien-Bryan, C. & Fuller, S. D. The organization of the spike complex of Semliki Forest virus. J. Mol. Biol. 236, 572\u2013583 (1994).","journal-title":"J. Mol. Biol."},{"key":"64181_CR16","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0969-2126(94)00083-2","volume":"2","author":"JM Kenney","year":"1994","unstructured":"Kenney, J. M., Sj\u00f6berg, M., Garoff, H. & Fuller, S. D. Visualization of fusion activation in the Semliki Forest virus spike. Structure 2, 823\u2013832 (1994).","journal-title":"Structure"},{"key":"64181_CR17","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41586-021-04326-0","volume":"602","author":"LE Clark","year":"2022","unstructured":"Clark, L. E. et al. VLDLR and ApoER2 are receptors for multiple alphaviruses. Nature 602, 475\u2013480 (2022).","journal-title":"Nature"},{"key":"64181_CR18","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.cell.2023.03.032","volume":"186","author":"D Cao","year":"2023","unstructured":"Cao, D., Ma, B., Cao, Z., Zhang, X. & Xiang, Y. Structure of Semliki Forest virus in complex with its receptor VLDLR. Cell 186, 2208\u20132218.e2215 (2023).","journal-title":"Cell"},{"key":"64181_CR19","doi-asserted-by":"publisher","first-page":"8342","DOI":"10.1158\/0008-5472.CAN-08-0251","volume":"68","author":"A Ketola","year":"2008","unstructured":"Ketola, A. et al. Oncolytic Semliki forest virus vector as a novel candidate against unresectable osteosarcoma. Cancer Res. 68, 8342\u20138350 (2008).","journal-title":"Cancer Res."},{"key":"64181_CR20","doi-asserted-by":"publisher","first-page":"7185","DOI":"10.1158\/0008-5472.CAN-05-2214","volume":"66","author":"MJ V\u00e4h\u00e4-Koskela","year":"2006","unstructured":"V\u00e4h\u00e4-Koskela, M. J. et al. Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice. Cancer Res. 66, 7185\u20137194 (2006).","journal-title":"Cancer Res."},{"key":"64181_CR21","doi-asserted-by":"publisher","first-page":"7041","DOI":"10.1073\/pnas.96.12.7041","volume":"96","author":"MU Ehrengruber","year":"1999","unstructured":"Ehrengruber, M. U. et al. Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures. Proc. Natl. Acad. Sci. 96, 7041\u20137046 (1999).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"64181_CR22","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1006\/mcne.2001.0982","volume":"17","author":"MU Ehrengruber","year":"2001","unstructured":"Ehrengruber, M. U. et al. Gene transfer into neurons from Hippocampal slices: comparison of recombinant Semliki forest virus, adenovirus, adeno-associated virus, lentivirus, and measles virus. Mol. Cell. Neurosci. 17, 855\u2013871 (2001).","journal-title":"Mol. Cell. Neurosci."},{"key":"64181_CR23","doi-asserted-by":"publisher","first-page":"7536","DOI":"10.1128\/JVI.03645-14","volume":"89","author":"MC Ferguson","year":"2015","unstructured":"Ferguson, M. C. et al. Ability of the encephalitic arbovirus Semliki forest virus to cross the blood-brain barrier is determined by the charge of the E2 glycoprotein. J. Virol. 89, 7536\u20137549 (2015).","journal-title":"J. Virol."},{"key":"64181_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55493-3","volume":"15","author":"M Martikainen","year":"2024","unstructured":"Martikainen, M. et al. VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier. Nat. Commun. 15, 10718 (2024).","journal-title":"Nat. Commun."},{"key":"64181_CR25","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00262-018-2276-z","volume":"68","author":"A Singh","year":"2019","unstructured":"Singh, A., Koutsoumpli, G., van de Wall, S. & Daemen, T. An alphavirus-based therapeutic cancer vaccine: from design to clinical trial. Cancer Immunol. Immunother. 68, 849\u2013859 (2019).","journal-title":"Cancer Immunol. Immunother."},{"key":"64181_CR26","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1016\/j.cell.2023.05.019","volume":"186","author":"MS Sutton","year":"2023","unstructured":"Sutton, M. S. et al. Vaccine elicitation and structural basis for antibody protection against alphaviruses. Cell 186, 2672\u20132689.e2625 (2023).","journal-title":"Cell"},{"key":"64181_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nm.2105","volume":"16","author":"W Akahata","year":"2010","unstructured":"Akahata, W. et al. A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat. Med. 16, 334\u2013338 (2010).","journal-title":"Nat. Med."},{"key":"64181_CR28","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ymthe.2020.11.002","volume":"29","author":"FL Komdeur","year":"2021","unstructured":"Komdeur, F. L. et al. First-in-human phase I clinical trial of an SFV-based RNA replicon cancer vaccine against HPV-induced cancers. Mol. Ther. 29, 611\u2013625 (2021).","journal-title":"Mol. Ther."},{"key":"64181_CR29","doi-asserted-by":"publisher","unstructured":"Wolf Yuri, I. et al. Origins and evolution of the global RNA virome. mBio 9, https:\/\/doi.org\/10.1128\/mbio.02329-18 (2018).","DOI":"10.1128\/mbio.02329-18"},{"key":"64181_CR30","doi-asserted-by":"crossref","unstructured":"Palucha, A. et al. in Progress in Nucleic Acid Research and Molecular Biology, vol. 80, 135\u2013168 (Academic Press, 2005).","DOI":"10.1016\/S0079-6603(05)80004-2"},{"key":"64181_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav3113","volume":"11","author":"S-Y Ko","year":"2019","unstructured":"Ko, S.-Y. et al. A virus-like particle vaccine prevents equine encephalitis virus infection in nonhuman primates. Sci. Transl. Med. 11, eaav3113 (2019).","journal-title":"Sci. Transl. Med."},{"key":"64181_CR32","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/j.cell.2021.03.025","volume":"184","author":"JK Nu\u00f1ez","year":"2021","unstructured":"Nu\u00f1ez, J. K. et al. Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing. Cell 184, 2503\u20132519.e2517 (2021).","journal-title":"Cell"},{"key":"64181_CR33","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"64181_CR34","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","volume":"19","author":"M Mirdita","year":"2022","unstructured":"Mirdita, M. et al. ColabFold: making protein folding accessible to all. Nat. Methods 19, 679\u2013682 (2022).","journal-title":"Nat. Methods"},{"key":"64181_CR35","first-page":"914","volume":"4","author":"Z Lu","year":"2021","unstructured":"Lu, Z. et al. Lentiviral capsid-mediated Streptococcus pyogenes Cas9 ribonucleoprotein delivery for efficient and safe multiplex genome editing. CRISPR J. 4, 914\u2013928 (2021).","journal-title":"CRISPR J."},{"key":"64181_CR36","doi-asserted-by":"crossref","unstructured":"Tuittila, M. T., Santagati, M. G., R\u00f6ytt\u00e4, M., M\u00e4\u00e4tt\u00e4, J. A. & Hinkkanen, A. E. Replicase Complex Genes of Semliki Forest Virus Confer Lethal Neurovirulence. J. Virol. 74, 4579\u20134589 (2000).","DOI":"10.1128\/JVI.74.10.4579-4589.2000"},{"key":"64181_CR37","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","volume":"28","author":"JL Shirley","year":"2020","unstructured":"Shirley, J. L., de Jong, Y. P., Terhorst, C. & Herzog, R. W. Immune responses to viral gene therapy vectors. Mol. Ther. 28, 709\u2013722 (2020).","journal-title":"Mol. Ther."},{"key":"64181_CR38","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1182\/blood-2005-08-3229","volume":"107","author":"CD Scallan","year":"2006","unstructured":"Scallan, C. D. et al. Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice. Blood 107, 1810\u20131817 (2006).","journal-title":"Blood"},{"key":"64181_CR39","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1182\/blood-2006-04-017913","volume":"108","author":"H Jiang","year":"2006","unstructured":"Jiang, H. et al. Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy. Blood 108, 3321\u20133328 (2006).","journal-title":"Blood"},{"key":"64181_CR40","first-page":"503","volume":"76","author":"K Lundstrom","year":"2003","unstructured":"Lundstrom, K. & Ehrengruber, M. U. Semliki Forest virus (SFV) vectors in neurobiology and gene therapy. Methods Mol. Med. 76, 503\u2013523 (2003).","journal-title":"Methods Mol. Med."},{"key":"64181_CR41","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Navarro, M. & Giralt, E. Peptide shuttles for blood-brain barrier drug delivery. Pharmaceutics 14, https:\/\/mdpi-res.com\/d_attachment\/pharmaceutics\/pharmaceutics-14-01874\/article_deploy\/pharmaceutics-14-01874-v2.pdf?version=1662537283 (2022).","DOI":"10.3390\/pharmaceutics14091874"},{"key":"64181_CR42","doi-asserted-by":"crossref","unstructured":"Kouhi, A. et al. Brain disposition of antibody-based therapeutics: dogma, approaches and perspectives. Int. J. Mol. Sci. 22, https:\/\/mdpi-res.com\/d_attachment\/ijms\/ijms-22-06442\/article_deploy\/ijms-22-06442.pdf?version=1623839392 (2021).","DOI":"10.3390\/ijms22126442"},{"key":"64181_CR43","doi-asserted-by":"crossref","unstructured":"Sun, J.-M. et al. Advances in antibody-based therapeutics for cerebral ischemia. Pharmaceutics 15, 145 (2023).","DOI":"10.3390\/pharmaceutics15010145"},{"key":"64181_CR44","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jconrel.2020.09.042","volume":"328","author":"J-M Rabanel","year":"2020","unstructured":"Rabanel, J.-M., Piec, P.-A., Landri, S., Patten, S. A. & Ramassamy, C. Transport of PEGylated-PLA nanoparticles across a blood brain barrier model, entry into neuronal cells and in vivo brain bioavailability. J. Controlled Rel. 328, 679\u2013695 (2020).","journal-title":"J. Controlled Rel."},{"key":"64181_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15623","volume":"8","author":"C-F Cho","year":"2017","unstructured":"Cho, C.-F. et al. Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents. Nat. Commun. 8, 15623 (2017).","journal-title":"Nat. Commun."},{"key":"64181_CR46","doi-asserted-by":"crossref","unstructured":"Majerova, P. et al. Novel blood\u2013brain barrier shuttle peptides discovered through the phage display method. Molecules 25, https:\/\/mdpi-res.com\/d_attachment\/molecules\/molecules-25-00874\/article_deploy\/molecules-25-00874-v2.pdf?version=1582342613 (2020).","DOI":"10.3390\/molecules25040874"},{"key":"64181_CR47","first-page":"E28","volume":"114","author":"IS Kim","year":"2017","unstructured":"Kim, I. S. et al. Mechanism of membrane fusion induced by vesicular stomatitis virus G protein. Proc. Natl. Acad. Sci. 114, E28\u2013E36 (2017).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"64181_CR48","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.virol.2015.11.012","volume":"488","author":"S Hu","year":"2016","unstructured":"Hu, S., Mohan Kumar, D., Sax, C., Schuler, C. & Akkina, R. Pseudotyping of lentiviral vector with novel vesiculovirus envelope glycoproteins derived from Chandipura and Piry viruses. Virology 488, 162\u2013168 (2016).","journal-title":"Virology"},{"key":"64181_CR49","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1006\/mthe.2000.0027","volume":"1","author":"R Schroers","year":"2000","unstructured":"Schroers, R. et al. Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system. Mol. Ther. 1, 171\u2013179 (2000).","journal-title":"Mol. Ther."},{"key":"64181_CR50","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1016\/j.cell.2023.03.033","volume":"186","author":"SM Hindi","year":"2023","unstructured":"Hindi, S. M. et al. Enveloped viruses pseudotyped with mammalian myogenic cell fusogens target skeletal muscle for gene delivery. Cell 186, 2062\u20132077.e2017 (2023).","journal-title":"Cell"},{"key":"64181_CR51","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.ijbiomac.2022.04.114","volume":"209","author":"M Yadav","year":"2022","unstructured":"Yadav, M., Atala, A. & Lu, B. Developing all-in-one virus-like particles for Cas9 mRNA\/single guide RNA co-delivery and aptamer-containing lentiviral vectors for improved gene expression. Int. J. Biol. Macromol. 209, 1260\u20131270 (2022).","journal-title":"Int. J. Biol. Macromol."},{"key":"64181_CR52","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/hum.2009.051","volume":"21","author":"D Schenkwein","year":"2009","unstructured":"Schenkwein, D., Turkki, V., K\u00e4rkk\u00e4inen, H.-R., Airenne, K. & Yl\u00e4-Herttuala, S. Production of HIV-1 integrase fusion protein-carrying lentiviral vectors for gene therapy and protein transduction. Hum. Gene Ther. 21, 589\u2013602 (2009).","journal-title":"Hum. Gene Ther."},{"key":"64181_CR53","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1038\/mt.2010.150","volume":"18","author":"G Michel","year":"2010","unstructured":"Michel, G., Yu, Y., Chang, T. & Yee, J.-K. Site-specific gene insertion mediated by a Cre-loxP-carrying lentiviral vector. Mol. Ther. 18, 1814\u20131821 (2010).","journal-title":"Mol. Ther."},{"key":"64181_CR54","doi-asserted-by":"publisher","first-page":"7610","DOI":"10.1093\/nar\/gkr524","volume":"39","author":"A Izmiryan","year":"2011","unstructured":"Izmiryan, A., Basmaciogullari, S., Henry, A., Paques, F. & Danos, O. Efficient gene targeting mediated by a lentiviral vector-associated meganuclease. Nucleic Acids Res. 39, 7610\u20137619 (2011).","journal-title":"Nucleic Acids Res."},{"key":"64181_CR55","doi-asserted-by":"publisher","unstructured":"Hamilton, J. R. et al. Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering. Cell Rep. 35, https:\/\/doi.org\/10.1016\/j.celrep.2021.109207 (2021).","DOI":"10.1016\/j.celrep.2021.109207"},{"key":"64181_CR56","doi-asserted-by":"publisher","unstructured":"An, M. et al. Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-023-02078-y (2024).","DOI":"10.1038\/s41587-023-02078-y"},{"key":"64181_CR57","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1021\/acs.nanolett.0c04640","volume":"21","author":"C Calcines-Cruz","year":"2021","unstructured":"Calcines-Cruz, C., Finkelstein, I. J. & Hernandez-Garcia, A. CRISPR-guided programmable self-assembly of artificial virus-like nucleocapsids. Nano Lett. 21, 2752\u20132757 (2021).","journal-title":"Nano Lett."},{"key":"64181_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2022.167924","volume":"435","author":"A Chameettachal","year":"2023","unstructured":"Chameettachal, A., Mustafa, F. & Rizvi, T. A. Understanding retroviral life cycle and its genomic RNA packaging. J. Mol. Biol. 435, 167924 (2023).","journal-title":"J. Mol. Biol."},{"key":"64181_CR59","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1126\/science.1240933","volume":"341","author":"D Gao","year":"2013","unstructured":"Gao, D. et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341, 903\u2013906 (2013).","journal-title":"Science"},{"key":"64181_CR60","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.4161\/hv.25813","volume":"9","author":"M Isaguliants","year":"2013","unstructured":"Isaguliants, M. et al. Oxidative stress induced by HIV-1 reverse transcriptase modulates the enzyme\u2019s performance in gene immunization. Hum. Vaccines Immunotherapeutics 9, 2111\u20132119 (2013).","journal-title":"Hum. Vaccines Immunotherapeutics"},{"key":"64181_CR61","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.omtm.2022.11.009","volume":"28","author":"K Cornetta","year":"2023","unstructured":"Cornetta, K., Lin, T.-Y., Pellin, D. & Kohn, D. B. Meeting FDA Guidance recommendations for replication-competent virus and insertional oncogenesis testing. Mol. Ther. Methods Clin. Dev. 28, 28\u201339 (2023).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"64181_CR62","doi-asserted-by":"publisher","first-page":"e1009603","DOI":"10.1371\/journal.ppat.1009603","volume":"17","author":"L Contu","year":"2021","unstructured":"Contu, L., Balistreri, G., Domanski, M., Uldry, A.-C. & M\u00fchlemann, O. Characterisation of the Semliki Forest Virus-host cell interactome reveals the viral capsid protein as an inhibitor of nonsense-mediated mRNA decay. PLOS Pathog. 17, e1009603 (2021).","journal-title":"PLOS Pathog."},{"key":"64181_CR63","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1128\/jvi.5.5.632-638.1970","volume":"5","author":"KB Tan","year":"1970","unstructured":"Tan, K. B. Electron microscopy of cells infected with Semliki forest virus temperature-sensitive mutants: correlation of ultrastructural and physiological observations. J. Virol. 5, 632\u2013638 (1970).","journal-title":"J. Virol."},{"key":"64181_CR64","doi-asserted-by":"publisher","unstructured":"Qian, Q. et al. The capsid protein of Semliki forest virus antagonizes RNA interference in mammalian cells. J. Virol. 94, https:\/\/doi.org\/10.1128\/jvi.01233-19 (2020).","DOI":"10.1128\/jvi.01233-19"},{"key":"64181_CR65","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2019.1596016","volume":"8","author":"D Bachurski","year":"2019","unstructured":"Bachurski, D. et al. Extracellular vesicle measurements with nanoparticle tracking analysis - an accuracy and repeatability comparison between NanoSight NS300 and ZetaView. J. Extracell. Vesicles 8, 1596016 (2019).","journal-title":"J. Extracell. Vesicles"},{"key":"64181_CR66","doi-asserted-by":"publisher","first-page":"855","DOI":"10.15252\/msb.20156423","volume":"12","author":"Z Cheng","year":"2016","unstructured":"Cheng, Z. et al. Differential dynamics of the mammalian mRNA and protein expression response to misfolding stress. Mol. Syst. Biol. 12, 855 (2016).","journal-title":"Mol. Syst. Biol."},{"key":"64181_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18948-x","volume":"11","author":"X-P Hu","year":"2020","unstructured":"Hu, X.-P., Dourado, H., Schubert, P. & Lercher, M. J. The protein translation machinery is expressed for maximal efficiency in Escherichia coli. Nat. Commun. 11, 5260 (2020).","journal-title":"Nat. Commun."},{"key":"64181_CR68","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.coi.2008.01.002","volume":"20","author":"O Takeuchi","year":"2008","unstructured":"Takeuchi, O. & Akira, S. MDA5\/RIG-I and virus recognition. Curr. Opin. Immunol. 20, 17\u201322 (2008).","journal-title":"Curr. Opin. Immunol."},{"key":"64181_CR69","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","volume":"20","author":"J Rehwinkel","year":"2020","unstructured":"Rehwinkel, J. & Gack, M. U. RIG-I-like receptors: their regulation and roles in RNA sensing. Nat. Rev. Immunol. 20, 537\u2013551 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"64181_CR70","doi-asserted-by":"crossref","unstructured":"Lozhkov, A. A. et al. Simultaneous detection of RIG-1, MDA5, and IFIT-1 expression is a convenient tool for evaluation of the interferon-mediated response. Viruses 14, 2090 (2022).","DOI":"10.3390\/v14102090"},{"key":"64181_CR71","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41423-020-00602-7","volume":"18","author":"K Onomoto","year":"2021","unstructured":"Onomoto, K., Onoguchi, K. & Yoneyama, M. Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors. Cell. Mol. Immunol. 18, 539\u2013555 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"64181_CR72","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/imr.13022","volume":"304","author":"D Thoresen","year":"2021","unstructured":"Thoresen, D. et al. The molecular mechanism of RIG-I activation and signaling. Immunol. Rev. 304, 154\u2013168 (2021).","journal-title":"Immunol. Rev."},{"key":"64181_CR73","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.ajpath.2018.01.010","volume":"188","author":"A Pant","year":"2018","unstructured":"Pant, A. et al. Plasminogen activator inhibitor-1 reduces tissue-type plasminogen activator\u2013dependent fibrinolysis and intrahepatic hemorrhage in experimental acetaminophen overdose.  Am. J. Pathol. 188, 1204\u20131212 (2018).","journal-title":"Am. J. Pathol."},{"key":"64181_CR74","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s12276-020-0397-x","volume":"52","author":"H Lin","year":"2020","unstructured":"Lin, H. et al. Therapeutics targeting the fibrinolytic system. Exp. Mol. Med. 52, 367\u2013379 (2020).","journal-title":"Exp. Mol. Med."},{"key":"64181_CR75","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.cell.2015.01.040","volume":"160","author":"M Dittmann","year":"2015","unstructured":"Dittmann, M. et al. A serpin shapes the extracellular environment to prevent influenza A virus maturation. Cell 160, 631\u2013643 (2015).","journal-title":"Cell"},{"key":"64181_CR76","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/84209","volume":"2","author":"C Gerard","year":"2001","unstructured":"Gerard, C. & Rollins, B. J. Chemokines and disease. Nat. Immunol. 2, 108\u2013115 (2001).","journal-title":"Nat. Immunol."},{"key":"64181_CR77","doi-asserted-by":"publisher","first-page":"16555","DOI":"10.1074\/jbc.M009068200","volume":"276","author":"N Ashida","year":"2001","unstructured":"Ashida, N., Arai, H., Yamasaki, M. & Kita, T. Distinct signaling pathways for MCP-1-dependent Integrin activation and chemotaxis*. J. Biol. Chem. 276, 16555\u201316560 (2001).","journal-title":"J. Biol. Chem."},{"key":"64181_CR78","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1182\/blood.V97.2.359","volume":"97","author":"B Cambien","year":"2001","unstructured":"Cambien, B., Pomeranz, M., Millet, M.-A., Rossi, B. & Schmid-Alliana, A. Signal transduction involved in MCP-1\u2013mediated monocytic transendothelial migration. Blood 97, 359\u2013366 (2001).","journal-title":"Blood"},{"key":"64181_CR79","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.4049\/jimmunol.160.8.4034","volume":"160","author":"P Proost","year":"1998","unstructured":"Proost, P. et al. Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6\u201376) as a natural chemokine inhibitor1.  J. Immunol. 160, 4034\u20134041 (1998).","journal-title":"J. Immunol."},{"key":"64181_CR80","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1146\/annurev.immunol.24.021605.090727","volume":"24","author":"A Ma","year":"2006","unstructured":"Ma, A., Koka, R. & Burkett, P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24, 657\u2013679 (2006).","journal-title":"Annu. Rev. Immunol."},{"key":"64181_CR81","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1073\/pnas.1318281111","volume":"111","author":"G Cui","year":"2014","unstructured":"Cui, G. et al. Characterization of the IL-15 niche in primary and secondary lymphoid organs in vivo. Proc. Natl. Acad. Sci. USA 111, 1915\u20131920 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"64181_CR82","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1126\/science.7667639","volume":"269","author":"DN Cook","year":"1995","unstructured":"Cook, D. N. et al. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269, 1583\u20131585 (1995).","journal-title":"Science"},{"key":"64181_CR83","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1128\/JVI.77.7.4004-4014.2003","volume":"77","author":"MJ Trifilo","year":"2003","unstructured":"Trifilo, M. J., Bergmann, C. C., Kuziel, W. A. & Lane, T. E. CC chemokine ligand 3 (CCL3) regulates CD8(+)-T-cell effector function and migration following viral infection. J. Virol. 77, 4004\u20134014 (2003).","journal-title":"J. Virol."},{"key":"64181_CR84","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3892\/br.2016.639","volume":"4","author":"Z Guo","year":"2016","unstructured":"Guo, Z., Peng, H., Kang, J. & Sun, D. Cell-penetrating peptides: possible transduction mechanisms and therapeutic applications. Biomed. Rep. 4, 528\u2013534 (2016).","journal-title":"Biomed. Rep."},{"key":"64181_CR85","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.tibs.2015.10.004","volume":"40","author":"WB Kauffman","year":"2015","unstructured":"Kauffman, W. B., Fuselier, T., He, J. & Wimley, W. C. Mechanism matters: a taxonomy of cell penetrating peptides. Trends Biochem. Sci. 40, 749\u2013764 (2015).","journal-title":"Trends Biochem. Sci."},{"key":"64181_CR86","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1089\/hum.2019.264","volume":"31","author":"A Westhaus","year":"2020","unstructured":"Westhaus, A. et al. High-throughput in vitro, ex vivo, and in vivo screen of adeno-associated virus vectors based on physical and functional transduction. Hum. Gene Ther. 31, 575\u2013589 (2020).","journal-title":"Hum. Gene Ther."},{"key":"64181_CR87","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF00986961","volume":"19","author":"NK Gray","year":"1994","unstructured":"Gray, N. K. & Hentze, M. W. Regulation of protein synthesis by mRNA structure. Mol. Biol. Rep. 19, 195\u2013200 (1994).","journal-title":"Mol. Biol. Rep."},{"key":"64181_CR88","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ceb.2008.02.004","volume":"20","author":"AJ Rodriguez","year":"2008","unstructured":"Rodriguez, A. J., Czaplinski, K., Condeelis, J. S. & Singer, R. H. Mechanisms and cellular roles of local protein synthesis in mammalian cells. Curr. Opin. Cell Biol. 20, 144\u2013149 (2008).","journal-title":"Curr. Opin. Cell Biol."},{"key":"64181_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35795-8","volume":"14","author":"JM Lee","year":"2023","unstructured":"Lee, J. M., Hammar\u00e9n, H. M., Savitski, M. M. & Baek, S. H. Control of protein stability by post-translational modifications. Nat. Commun. 14, 201 (2023).","journal-title":"Nat. Commun."},{"key":"64181_CR90","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","volume":"9","author":"J-H Wang","year":"2024","unstructured":"Wang, J.-H., Gessler, D. J., Zhan, W., Gallagher, T. L. & Gao, G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Sig. Transduct. Target. Ther. 9, 78 (2024).","journal-title":"Sig. Transduct. Target. Ther."},{"key":"64181_CR91","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/mt.2009.246","volume":"18","author":"L Wang","year":"2010","unstructured":"Wang, L. et al. Systematic evaluation of AAV vectors for liver directed gene transfer in murine models. Mol. Ther. 18, 118\u2013125 (2010).","journal-title":"Mol. Ther."},{"key":"64181_CR92","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1089\/hum.2011.183","volume":"23","author":"L Wang","year":"2012","unstructured":"Wang, L., Wang, H., Bell, P., McMenamin, D. & Wilson, J. M. Hepatic gene transfer in neonatal mice by adeno-associated virus serotype 8 vector. Hum. Gene Ther. 23, 533\u2013539 (2012).","journal-title":"Hum. Gene Ther."},{"key":"64181_CR93","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.omtm.2019.10.007","volume":"15","author":"KS Hanlon","year":"2019","unstructured":"Hanlon, K. S. et al. Selection of an efficient AAV vector for robust CNS transgene expression. Mol. Ther. - Methods Clin. Dev. 15, 320\u2013332 (2019).","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"64181_CR94","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.omtm.2020.10.011","volume":"19","author":"SN Mathiesen","year":"2020","unstructured":"Mathiesen, S. N., Lock, J. L., Schoderboeck, L., Abraham, W. C. & Hughes, S. M. CNS transduction benefits of AAV-PHP.eB over AAV9 are dependent on administration route and mouse strain. Mol. Ther. Methods Clin. Dev. 19, 447\u2013458 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"64181_CR95","doi-asserted-by":"publisher","unstructured":"Hamilton, J. R. et al. In vivo human T cell engineering with enveloped delivery vehicles. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-023-02085-z (2024).","DOI":"10.1038\/s41587-023-02085-z"},{"key":"64181_CR96","doi-asserted-by":"publisher","unstructured":"Yin, D. et al. Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers. Nat. Biomed. Eng. https:\/\/doi.org\/10.1038\/s41551-024-01208-4 (2024).","DOI":"10.1038\/s41551-024-01208-4"},{"key":"64181_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40788-8","volume":"14","author":"D Strebinger","year":"2023","unstructured":"Strebinger, D. et al. Cell type-specific delivery by modular envelope design. Nat. Commun. 14, 5141 (2023).","journal-title":"Nat. Commun."},{"key":"64181_CR98","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/nbt1291-1356","volume":"9","author":"P Liljestr\u00f6m","year":"1991","unstructured":"Liljestr\u00f6m, P. & Garoff, H. A new generation of animal cell expression vectors based on the Semliki forest virus replicon. Bio Technol. 9, 1356\u20131361 (1991).","journal-title":"Bio Technol."},{"key":"64181_CR99","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jbiotec.2008.12.009","volume":"139","author":"R Benmaamar","year":"2009","unstructured":"Benmaamar, R., Astray, R. M., Wagner, R. & Pereira, C. A. High-level expression of rabies virus glycoprotein with the RNA-based Semliki Forest Virus expression vector. J. Biotechnol. 139, 283\u2013290 (2009).","journal-title":"J. Biotechnol."},{"key":"64181_CR100","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1101\/pdb.prot070151","volume":"2012","author":"K Lundstrom","year":"2012","unstructured":"Lundstrom, K. Generation of recombinant alphaviral vectors. Cold Spring Harb. Protoc. 2012, 825\u2013831 (2012).","journal-title":"Cold Spring Harb. Protoc."},{"key":"64181_CR101","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0005-2736(02)00721-6","volume":"1610","author":"K Lundstrom","year":"2003","unstructured":"Lundstrom, K. Semliki Forest virus vectors for rapid and high-level expression of integral membrane proteins. Biochim. Biophys. Acta 1610, 90\u201396 (2003).","journal-title":"Biochim. Biophys. Acta"},{"key":"64181_CR102","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s10616-019-00337-y","volume":"71","author":"SF Su\u00e1rez-Pati\u00f1o","year":"2019","unstructured":"Su\u00e1rez-Pati\u00f1o, S. F. et al. Semliki Forest Virus replicon particles production in serum-free medium BHK-21 cell cultures and their use to express different proteins. Cytotechnology 71, 949\u2013962 (2019).","journal-title":"Cytotechnology"},{"key":"64181_CR103","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1023\/A:1007974121182","volume":"24","author":"HD Blasey","year":"1997","unstructured":"Blasey, H. D., Lundstr\u00f6m, K., Tate, S. & Bernard, A. R. Recombinant protein production using the Semliki Forest Virus expression system. Cytotechnology 24, 65\u201372 (1997).","journal-title":"Cytotechnology"},{"key":"64181_CR104","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29376","volume":"96","author":"Y Huang","year":"2024","unstructured":"Huang, Y. et al. A novel three-plasmid packaging system for chimeric SFV\/SIN VRPs derived from Semliki Forest virus and Sindbis virus as a candidate gene delivery vector. J. Med. Virol. 96, e29376 (2024).","journal-title":"J. Med. Virol."},{"key":"64181_CR105","doi-asserted-by":"publisher","unstructured":"Han, J. et al. Rational engineering of adeno-associated virus capsid enhances human hepatocyte tropism and reduces immunogenicity. Cell Prolif. e13339 https:\/\/doi.org\/10.1111\/cpr.13339 (2022).","DOI":"10.1111\/cpr.13339"},{"key":"64181_CR106","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13565","volume":"57","author":"M Dai","year":"2024","unstructured":"Dai, M. et al. Discovering human cell-compatible gene therapy virus variants via optimized screening in mouse models. Cell Prolif. 57, e13565 (2024).","journal-title":"Cell Prolif."},{"key":"64181_CR107","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","volume":"65","author":"X Chen","year":"2013","unstructured":"Chen, X., Zaro, J. L. & Shen, W.-C. Fusion protein linkers: Property, design and functionality. Adv. Drug Deliv. Rev. 65, 1357\u20131369 (2013).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"64181_CR108","doi-asserted-by":"publisher","first-page":"6565","DOI":"10.1021\/acs.biochem.7b00902","volume":"56","author":"M van Rosmalen","year":"2017","unstructured":"van Rosmalen, M., Krom, M. & Merkx, M. Tuning the flexibility of glycine-serine linkers to allow rational design of multidomain proteins. Biochemistry 56, 6565\u20136574 (2017).","journal-title":"Biochemistry"},{"key":"64181_CR109","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.tibtech.2016.01.001","volume":"34","author":"S Aday","year":"2016","unstructured":"Aday, S., Cecchelli, R., Hallier-Vanuxeem, D., Dehouck, M. P. & Ferreira, L. Stem cell-based human blood\u2013brain barrier models for drug discovery and delivery. Trends Biotechnol. 34, 382\u2013393 (2016).","journal-title":"Trends Biotechnol."},{"key":"64181_CR110","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg6618","volume":"9","author":"TF Shay","year":"2023","unstructured":"Shay, T. F. et al. Primate-conserved carbonic anhydrase IV and murine-restricted LY6C1 enable blood-brain barrier crossing by engineered viral vectors. Sci. Adv. 9, eadg6618 (2023).","journal-title":"Sci. Adv."},{"key":"64181_CR111","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nn.2467","volume":"13","author":"L Madisen","year":"2010","unstructured":"Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133\u2013140 (2010).","journal-title":"Nat. Neurosci."},{"key":"64181_CR112","doi-asserted-by":"publisher","unstructured":"Chen, Y. et al. Synergistic engineering of CRISPR-Cas nucleases enables robust mammalian genome editing. Innovation 3, https:\/\/doi.org\/10.1016\/j.xinn.2022.100264 (2022).","DOI":"10.1016\/j.xinn.2022.100264"},{"key":"64181_CR113","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s11427-022-2237-1","volume":"66","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Computer-aided engineering of CRISPR-Cas proteins for enhanced human genome editing. Sci. China Life Sci. 66, 883\u2013886 (2023).","journal-title":"Sci. China Life Sci."},{"key":"64181_CR114","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41592-018-0048-5","volume":"15","author":"NC Yeo","year":"2018","unstructured":"Yeo, N. C. et al. An enhanced CRISPR repressor for targeted mammalian gene regulation. Nat. Methods 15, 611\u2013616 (2018).","journal-title":"Nat. Methods"},{"key":"64181_CR115","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224\u2013226 (2019).","journal-title":"Nat. Biotechnol."},{"key":"64181_CR116","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"64181_CR117","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/s41551-022-00938-7","volume":"6","author":"Y Yao","year":"2022","unstructured":"Yao, Y. et al. Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood\u2013brain barrier in rodents and primates. Nat. Biomed. Eng. 6, 1257\u20131271 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"64181_CR118","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","volume":"19","author":"T Chen","year":"2021","unstructured":"Chen, T. et al. The genome sequence archive family: toward explosive data growth and diverse data types. Genomics Proteom. Bioinforma. 19, 578\u2013583 (2021).","journal-title":"Genomics Proteom. Bioinforma."},{"key":"64181_CR119","doi-asserted-by":"publisher","first-page":"D27","DOI":"10.1093\/nar\/gkab951","volume":"50","author":"C-N Members","year":"2022","unstructured":"Members, C.-N. & Partners. Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2022. Nucleic Acids Res. 50, D27\u2013D38 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64181-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64181-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64181-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:07:37Z","timestamp":1760526457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64181-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":119,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64181"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64181-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"W.L., Q.Z., J.B.H., and H.Y.B. have filed a patent application with the China National Intellectual Property Administration covering the design and application of the SFV-based VLP system for gene and protein delivery (application number: 202311713766X; status: published). The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9157"}}